NCT01345682 · Interventional trial
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Overall registry status Completed
Phase 3
Conditions Carcinoma, Squamous Cell, Head and Neck Neoplasms
Delaware Valley sites
- 1200.43.00102 Boehringer Ingelheim Investigational Site · Philadelphia, PA · Philadelphia County
- 1200.43.00103 Boehringer Ingelheim Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory